Background {#Sec1}
==========

Gastric cancer, a leading cause of cancer-related death worldwide, remains the fourth most common malignancy \[[@CR1]\]. Complete tumor removal is essential to effectively treat resectable gastric cancer. To achieve complete resection, it is necessary to secure a sufficient tumor-free margin as confirmed macroscopically or endoscopically. However, tumors progress horizontally, sometimes spreading as submucosal infiltration while maintaining an apparently normal mucosa, which can mislead surgeons or endoscopists. Even if surgeons make careful efforts to achieve complete resection with negative margins, tumor cells are occasionally observed in resection margins (RM) on postoperative histological examinations, and such margins are diagnosed as microscopically positive (R1).

The correlation between microscopically positive RM and outcomes in patients with gastric cancer remains an issue of debate \[[@CR2], [@CR3]\]. However, several previous studies have reported that microscopically positive RM had an unfavorable impact on survival \[[@CR4]--[@CR7]\]. In other words, decreasing the risk of microscopically positive RM might benefit patients. Intraoperative frozen section diagnosis (IFSD) with a diagnostic accuracy of 93 to 100% has been used to detect tumor cells at the resection margin \[[@CR8]--[@CR10]\]. Although IFSD can decrease unanticipated positive RM, the procedure requires time, costs, and labor. Therefore, it should be performed in specific patients at high risk for positive RM. Stratification of patients based on the risk of positive RM is meaningful in terms of conserving resources.

The aims of this study were to evaluate risk factors for microscopic positive RM and to clarify which patients should undergo IFSD.

Methods {#Sec2}
=======

Patients {#Sec3}
--------

This retrospective cohort study examined 2757 patients who underwent surgery for gastric cancer or esophagogastric junction cancer from January 2000 through March 2018 in Kanagawa Cancer Center, Japan. All tumors fulfilled the following criteria: (1) histologically proven adenocarcinoma, (2) R0 or R1 resection, and (3) Gastric cancer and adenocarcinoma of the esophagogastric junction. The exclusion criteria were as follows: (1) stage IV cancer without ascites cytology positive reaction (2) R2 resection, and (3) Type I adenocarcinoma of the esophagogastric junction according to the Siewert classification \[[@CR11]\]. Cancer staging was based on the Union for International Cancer Control TNM classification, 7th edition \[[@CR12]\].

Surgical procedure {#Sec4}
------------------

i)Selection of gastrectomy

Gastrectomy and lymph node dissection were performed in accordance with the JGCA guidelines \[[@CR13]--[@CR15]\]. In short, distal gastrectomy or proximal gastrectomy was preformed when a sufficient proximal or distal RM could be obtained, if not so, total gastrectomy was performed. In principle, D1 or D1+ lymphadenectomy was indicated for cT1N0 tumors, and D2 lymphadenectomy was indicated for cT2--4 or cN+ tumors. ii)Determination of resection line of gastrectomy

The resection line was determined to secure a tumor-free margin as defined in the Japanese gastric cancer guidelines \[[@CR15]\]. In principle, a tumor-free margin larger than 3 cm was secured in cases of macroscopic type 1 or type 2 advanced cancer, while a tumor-free margin larger than 5 cm was secured in cases of macroscopic type 3, type 4, or type 5 advanced cancer as classified according to the classification of JGCA \[[@CR16]\]. If tumor invasion spread across the pylorus or cardia, the resection line was determined as the line expected to be tumor-free on intraoperative macroscopic examination. On the other hand, in early cancer, endoscopic marking with clips was performed as required before surgery to indicate the location of the tumor and resection line.

Finally, surgeons opened specimens of the removed stomachs and confirmed negative RM during operation. If surgeons could not macroscopically confirm that tumor-free margin was enough to meet rules as previously mentioned, IFSD was performed, and additional resection was done as necessary.

Evaluation and statistical analysis {#Sec5}
-----------------------------------

The patients were divided into a positive RM group and negative RM group on the basis of the microscopic findings of the longitudinal margins on definitive histopathological examinations.

The baseline characteristics were compared between the positive and negative RM groups by Pearson's chi-squared tests or Fisher's exact tests for categorical variables, as appropriate, and by the Mann-Whitney U tests for continuous variables. Risk factors for positive RM were analyzed by binomial logistic regression analysis. We used risk factors identified by logistic regression analysis to risk stratify the patients.

IBM SPSS Statistics for Windows, Version 24.0 (IBM Corp. Released 2016. Armonk, N.Y.) software was used for statistical analysis. *P*-values of less than 0.05 were considered to indicate statistical significance.

Results {#Sec6}
=======

Patient characteristics {#Sec7}
-----------------------

The demographic and clinicopathological characteristics of the patients are shown in Table [1](#Tab1){ref-type="table"}. Forty-nine patients (1.8%) with positive RM were studied. Among the 49 patients, there are no patients who received IFSD, and 27 (55.1%) had positive proximal RM, 15 (30.6%) had positive distal RM, and 7 (14.3%) had positive bilateral RM. There was no case with negative frozen section margins that turned out R1 on postoperative histological examination. Patients in the positive RM group received neoadjuvant chemotherapy (14.3% vs. 4.5%, *p* = 0.007) and total gastrectomy (59.2% vs. 35.4%, *p* \< 0.001) more frequently than those in the negative RM group. Remnant gastric cancer (12.2% vs. 2.5%, *p* = 0.002) and esophageal invasion (18.4% vs. 3.5%, *p* \< 0.001) were more frequent in the positive RM group than in the negative RM group. Tumor size in the positive RM group was larger than that in the negative RM group (105 mm vs. 41 mm, *p* \< 0.001). The proportions of tumors with undifferentiated type of histopathology (89.8% vs. 54.2%, *p* \< 0.001) and macroscopic type 4 (49% vs. 3.7%, *p* \< 0.001) were higher in the positive RM group than in the negative RM group. Patients in the positive RM group had more advanced tumors in terms of pT category, pN category, and pTNM stage. No patient had pT1 tumors in the positive RM group. Table 1Baseline demographic, clinicopathological characteristics in patients with positive margin (PM) and negative margin (NM). IQR: Interquartile Range; BMI: body mass index; ASA-PS: American Society of Anesthesiologists physical status classification system**PM (*n*** **= 49)NM (*n*** **= 2708)*P*valueNumber of patients%Number of patients%**Age (Median) (IQR)66 (55--71)65 (57--72)0.949Sex0.031 Male2755.1185668.5 Female2244.985231.5BMI (Median) (IQR)21.5 (19.3--23.5)22.0 (22.0--24.2)0.213ASA-PS0.847 11735.493634.8 23062.5171864 312.1321.2Not available122Neoadjuvant chemotherapy0.007 Yes714.31224.5 No4285.7258695.5Surgical approach0.004 Open4489.8191870.8 laparoscopic510.279029.2Gastrectomy\< 0.001 Distal1836.7171863.4 Proximal24.1311.1 Total2959.295935.4Thoracotomy0.290 Yes12.0180.7 No4898.0269099.3Remnant cancer0.002 Yes612.2682.5 No4387.8264097.5Esophageal invasion\< 0.001 Yes918.4943.5 No4081.6261496.5Tumor size (mm) Median (IQR)105 (71--147)--41 (26--65)--\< 0.001  ≥ 80 mm3430.629410.9\< 0.001  \< 80 mm1569.4240789.1Histopathological type\< 0.001 Differentiated510.2124145.8 Undifferentiated4489.8146754.2Macroscopic Type\< 0.001 Type012165261 Type100823 Type20031311.6 Type31326.528210.4 Type424491013.7 Type51122.427810.3pT category\< 0.001 T100157858.3 T248.237413.8 T3510.22388.8 T44081.651819.1pN category\< 0.001 N01326.5182767.5 N148.234412.7 N2714.32459 N3255129210.8pTNM stage\< 0.001 I24.1178365.8 II1122.445316.7 III72346.942315.6 IV1326.5491.8

Incidence rates and odds ratios of risk factors {#Sec8}
-----------------------------------------------

Table [2](#Tab2){ref-type="table"} shows the incidence rates and odds ratios of risk factors for positive RM on univariate and multivariate analyses. The incidence rates of positive RM were higher than 10% in patients who had tumor measuring ≥80 mm or macroscopic type 4 disease (10.4, 19.2%, respectively). On multivariate analysis, the independent significant risk factors associated with the incidence of positive RM were remnant gastric cancer (odds ratio \[OR\] 4.7, 95% CI 1.6--13.3), esophageal invasion (OR 6.3, 95% CI 2.4--16.5), tumor size ≥80 mm (OR 3.9, 95% CI 1.7--8.7), undifferentiated type of histopathology (OR 3.6, 95% CI 1.3--10.0), macroscopic type 4 (OR 3.7, 95% CI 1.7--8.0), and pT4 (OR 4.6, 95% CI 1.9--10.9). Table 2Incidence rates of positive resection margin and odds ratios in univariate and multivariate analysis. OR: odds ratio; CI: confidence interval**Number of positive resection margin**\
**(Incidence rate)Univariate OR**\
**(95% CI)*P*-valueMultivariate OR**\
**(95% CI)*P*-value**Neoadjuvant chemotherapy No42 (1.6%)1.01.0 Yes7 (5.4%)3.5 (1.5--8.0)0.0020.7 (0.2--1.9)0.593Remnant cancer No43 (1.6%)1.01.0 Yes6 (8.1%)5.41 (2.2--13.1)\< 0.0014.7 (1.6--13.3)0.003Esophageal invasion No41 (1.5%)1.01.0 Yes8 (7.8%)5.42 (2.4--11.8)\< 0.0016.3 (2.45--16.5)\< 0.001Tumor size  \< 80 mm15 (0.6%)1.01.0  ≥ 80 mm34 (10.4%)18.60 (10.01--34.56)\< 0.0013.9 (1.78--8.7)0.001Histopathological type Differentiated5 (0.4%)1.01.0 Undifferentiated44 (2.9%)7.44 (2.9--18.8)\< 0.0013.6 (1.3--10.0)0.012Macroscopic Type Other than Type425 (0.9%)1.01.0 Type424 (19.2%)25.02 (13.8--45.3)\< 0.0013.7 (1.7--8.0)0.001pT category T1--39 (0.4%)1.01.0 T440 (7.1%)18.6 (8.9--38.6)\< 0.0014.6 (1.9--10.9)\< 0.001

Patient risk stratification {#Sec9}
---------------------------

The identified six risk factors for positive RM on multivariate analysis were used to risk stratify the patients (Table [3](#Tab3){ref-type="table"}). In patients who had no risk factors for positive RM, incidence rate of positive RM was 0.1%. The incidence rate increased to 0.4% with one risk factor, 3.1% with two risk factors, 5.3% with three risk factors, 21.3% with four risk factors and 85.7% with five risk factors. No patient had all six risk factors. The incidence of positive RM increased progressively with an increase in the number of risk factors. The presence of three or more risk factors was associated with a significant increase in the odds ratio. Table 3Risk stratification. Incidence rate of positive resection margin by each number of the risk factors**Number of positive resection margin**\
**(Incidence rate)Univariate OR95% CI*P*value**Risk factors 01/956 (0.1%)0.0380.005--0.2770.001 15/1242 (0.4%)0.1350.053--0.342\< 0.001 210/325 (3.1%)1.940.96--3.930.064 37/132 (5.3%)3.441.51--7.810.003 420/94 (21.3%)24.513.2--45.3\< 0.001 56/7 (85.7%)377.544.4--3203.8\< 0.001*OR* Odds ratio, *CI* Confidence interval

Discussion {#Sec10}
==========

The incidence of positive RM in the entire cohort was not high (1.8%), as compared with that in previous studies evaluating macroscopically positive RM in patients with gastric cancer (1.8--8.2%) \[[@CR4]--[@CR7], [@CR17]\]. The results suggest that our surgical procedures and methods for evaluating appropriate resection lines were at high levels. Nevertheless, surgeons misdiagnosed the resection lines of specimens as being tumor-free, despite the fact that tumor cells remained. Therefore, to prevent unexpected microscopically positive RM, resection with wider excision or IFSD should be performed in cases with a high risk of positive RM.

Our study showed that remnant gastric cancer, esophageal invasion, a tumor size of ≥80 mm, undifferentiated type of histopathology, macroscopic type 4, and pT4 were risk factors for positive RM in patients with gastric cancer. Moreover, the risk of positive RM increased in patients with three or more of those risk factors. In particular, owing to high-risk associated with four (21.3%) or five factors (85.7%), IFSD should be considered in patients who have four risk factors and is mandatory in patients who have five risk factors. On the other hand, patients without any risk factors do not have to undergo IFSD, because the incidence rate of positive RM is extremely low (0.1%).

Previous studies have similarly reported that advanced T category, advanced N category, total gastrectomy, larger tumor, EGJ location, diffuse histology, and linitis plastica, which is also referred to as macroscopic type 4, \[[@CR3], [@CR18], [@CR19]\] are risk factors for positive RM. On the basis of these studies, we chose candidate risk factors for preoperatively predicting clinicopathological features. We did not adopt N category as one of the risk factors because it was not appropriate to substitute pN for cN owing to the low preoperative diagnostic accuracy (63.6%) \[[@CR20]\]. Remnant gastric cancer, which remains an unknown risk factor for positive RM in previous studies, was more frequent in the PM group of our study and was therefore adopted as a risk factor for remnant gastric cancer. Finally, six clinicopathological features were identified as risk factors on multivariate analysis in our study, although the factors other than remnant cancer have been reported previously. An innovation of our study was to stratify patients who have risk factors and to show how often microscopically positive RM occurred in patients with such risk factors. To our knowledge, no previous study has reported on risk stratification of positive RM in patients with gastric cancer.

Our study had some limitations that should be taken into consideration when interpreting the results. First, we used the pathological T category, not the clinical T category, as an indicator of the invasion depth of tumor. There were no pT1 tumors with positive RM in our study. To utilize this result, accurate preoperative diagnosis is essential. The preoperative diagnosis of cT1 gastric cancer is reported to have 92.4 to 95.4% accuracy \[[@CR21]--[@CR23]\]. The invasion depth was underestimated in 4.6 to 7.6% of the patients, who actually had advanced cancer. If the tumor is diagnosed to be being somewhat shallower than the actual depth, the actual resection margin distance would be shorter than the essential margin, which suggests that the incidence rate of positive RM may increase.

A second limitation was that we could not evaluate the margin distance between the tumor and resection line, which was shown to be a risk factor in other studies \[[@CR18]\]. Risk stratification in our study was useful for preoperatively estimating the risk of positive RM and for deciding whether IFSD should be performed. However, the estimated risk would change depending on the actual secured margin distance. A multicenter Italian study reported that a RM distance of less than 2 cm was a risk factor for T1 tumors, and a RM distance of less than 3 cm was a risk factor for T2 to T4 Lauren intestinal pattern tumors \[[@CR19]\]. The required margin distance should be evaluated in patients who have high-risk factors for positive RM in future studies.

Conclusions {#Sec11}
===========

In conclusion, patients with gastric cancer who have four or more risk factors from among remnant gastric cancer, esophageal invasion, tumor size ≥80 mm, undifferentiated type of histopathology, macroscopic type 4, and pT4, have a high risk of macroscopically positive RM despite macroscopically negative margins as evaluated on intraoperative examination. In such patients, resection with wider excision should be performed as much as possible, or IFSD should be performed to confirm whether the resection margin is negative or positive.
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